Transforming growth factor-beta expression in prostate neoplasia

Area of Science:

• Urology
• Oncology
• Molecular Biology

Background:

• Transforming growth factor-beta (TGF-β) signaling plays a crucial role in cellular processes.
• Dysregulation of TGF-β signaling is implicated in various cancers, including prostate neoplasia.

Purpose of the Study:

• To investigate the expression of TGF-β isoforms (1, 2, 3) and their receptors (type I and II) in benign prostatic hyperplasia (BPH), prostatic intraepithelial neoplasia (PIN), and prostate carcinoma.
• To correlate TGF-β and receptor expression with epithelial and stromal compartments and tumor differentiation (Gleason score).

Main Methods:

• Immunohistochemistry was performed on 60 prostate neoplasm samples.
• Antibodies against TGF-β1, -β2, -β3, TGF-β receptor type I (RI), and TGF-β receptor type II (RII) were used.

Main Results:

• TGF-β proteins and receptors were more highly expressed in prostate carcinoma compared to PIN and BPH.
• Significant differences in epithelial vs. stromal expression were observed in BPH for all isoforms and receptors.
• Prostate cancer cells may escape TGF-β's growth-inhibitory effects due to altered protein and receptor expression.

Conclusions:

• Both malignant and non-malignant prostate tissues express TGF-β isoforms and receptors, suggesting paracrine and autocrine roles.
• Intact TGF-β signaling pathways are indicated in BPH and PIN by basal cell immunoreactivity.
• Altered TGF-β and receptor expression in prostate cancer may contribute to a more aggressive phenotype.